Digest Network Come funziona
Network
/
Società
Co
Non verificato

Compass Pathfinder Limited

Di cosa scriviamo

BiotecnologiaFarmaceuticaPsichiatriaSaluteScienza

23 comunicati stampa

Guarda tutti i comunicati
17/02/2026
Biotecnologia
Igiene alimentare
Sanità
Salute
Farmaceutica
Psichiatria
Scienza
Medicina - Varie
Mercato azionario
Compass Pathways Launches Proposed $150.0 Million Public Offering
Fonte
Compass Pathfinder Limited
Emittente
Business Wire
1.00
0
17/02/2026
Web e Social Network
Industria
Biotecnologia
Igiene alimentare
Sanità
Salute
Farmaceutica
Psichiatria
Scienza
Medicina - Varie
Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression
Fonte
Compass Pathfinder Limited
Emittente
Business Wire
1.00
0
16/02/2026
Scienza
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Psichiatria
Medicina - Varie
Analisi di mercato
Web e Social Network
Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials
Fonte
Compass Pathfinder Limited
Emittente
Business Wire
1.00
0
07/01/2026
Scienza
Psichiatria
Igiene alimentare
Medicina - Varie
Sanità
Biotecnologia
Farmaceutica
Salute
Web e Social Network
Mercato del lavoro
Industria
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD
Fonte
Compass Pathfinder Limited
Emittente
Business Wire
1.00
0
06/01/2026
Mercato del lavoro
Scienza
Psichiatria
Igiene alimentare
Medicina - Varie
Biotecnologia
Medicina alternativa
Farmaceutica
Salute
Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360
Fonte
Compass Pathfinder Limited
Emittente
Business Wire
1.00
0
09/12/2025
Web e Social Network
Scienza
Psichiatria
Igiene alimentare
Medicina - Varie
Sanità
Biotecnologia
Farmaceutica
Salute
Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression (TRD) and Clinical Trial Plans for Post-Traumatic Stress Disorder (PTSD) on January 7, 2026, 10:00am ET
Fonte
Compass Pathfinder Limited
Emittente
Business Wire
1.00
0
20/11/2025
Scienza
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
Eventi
Fiere
Compass Pathways to Participate in Two Investor Conferences in December
Fonte
Compass Pathfinder Limited
Emittente
Business Wire
1.00
0
05/11/2025
Biotecnologia
Igiene alimentare
Sanità
Salute
Farmaceutica
Psichiatria
Scienza
Medicina - Varie
Eventi
Web e Social Network
Compass Pathways to Participate in Stifel 2025 Healthcare Conference
Fonte
Compass Pathfinder Limited
Emittente
Business Wire
1.00
0
04/11/2025
Psichiatria
Scienza
Biotecnologia
Sanità
Medicina alternativa
Salute
Farmaceutica
Web e Social Network
Telefonia e Varie
Mercato azionario
Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months
Fonte
Compass Pathfinder Limited
Emittente
Business Wire
1.00
0
29/10/2025
Scienza
Psichiatria
Igiene alimentare
Medicina - Varie
Biotecnologia
Farmaceutica
Salute
Mercato del lavoro
Industria
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors
Fonte
Compass Pathfinder Limited
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0